ADAGE CAPITAL PARTNERS GP L.L.C. 13D/13G Filings for BioCryst Pharmaceuticals, Inc. (BCRX)

ADAGE CAPITAL PARTNERS GP L.L.C. 13D and 13G filings for BioCryst Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-04-17
5:30 pm
Purchase
2020-04-0813GBioCryst Pharmaceuticals, Inc.
BCRX
ADAGE CAPITAL PARTNERS GP L.L.C.2,500,000
1.620%
2,500,000increase
(New Position)
Filing